Market research
010600.KO Wellbiotec Co., Ltd
KO KRW Consumer Cyclical
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 50B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 1.15
Profile
Company facts
- Exchange
- KO
- Currency
- KRW
- Sector
- Consumer Cyclical
- Industry
- Textile Manufacturing
- ISIN
- KR7010600005
- Market cap
- 50B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 1.15
About
About Wellbiotec Co., Ltd
Wellbiotec Co., Ltd. produces and sells leather products in South Korea and internationally. The company provides leather products for shoes, hand bags, car seats, and handle covers. It also offers development, production, and sell of medicines and health functional foods; logistics consulting, transportation agency services, customs clearance, insurance, and storage services; and general and specialized medicines, health functional foods, protection products, diagnosis kits, cosmeceuticals, and other products. In addition, the company is involved in the import and export , logistics, transportation consulting; rare earth minerals business; ev charger; polydeoxyribonucleotide substance extracted from semen of salmon; and food and beverages businesses. The company was founded in 1975 and is headquartered in Seoul, South Korea.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 010600.KO discussion.
5 years, 5 months ago
Wellbiotec Co., Ltd is currently in a long term uptrend where the price is trading 11.0% above its 200 day moving average.
From a valuation standpoint, the stock is 35.7% more expensive than other stocks from the Consumer Cyclical sector with a price to sales ratio of 2.0.
Wellbiotec Co., Ltd's total revenue sank by 119.6% to $-5B since the same quarter in the previous year.
Its net income has dropped by 203.2% to $-33B since the same quarter in the previous year.
Finally, its free cash flow fell by 77.6% to $-844M since the same quarter in the previous year.
Based on the above factors, Wellbiotec Co., Ltd gets an overall score of 1/5.